188 related articles for article (PubMed ID: 16550361)
21. Clinical pharmacokinetics of tacrolimus after the first oral administration in renal transplant recipients on triple immunosuppressive therapy.
Velickovic-Radovanovic RM; Paunovic G; Mikov M; Djordjevic V; Stojanovic M; Catic-Djordjevic A; Cvetkovic T
Basic Clin Pharmacol Toxicol; 2010 Jun; 106(6):505-10. PubMed ID: 20102364
[TBL] [Abstract][Full Text] [Related]
22. Circadian and time-dependent variability in tacrolimus pharmacokinetics.
Park SI; Felipe CR; Pinheiro-Machado PG; Garcia R; Tedesco-Silva H; Medina-Pestana JO
Fundam Clin Pharmacol; 2007 Apr; 21(2):191-7. PubMed ID: 17391292
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.
Lumlertgul D; Noppakun K; Rojanasthien N; Kanchanarattanakorn K; Jittikanont S; Manoyot A; Bunnachak D; Ophascharoensuk V
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S73-8. PubMed ID: 17044457
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of tacrolimus in stable paediatric renal transplant recipients.
Claeys T; Van Dyck M; Van Damme-Lombaerts R
Pediatr Nephrol; 2010 Feb; 25(2):335-42. PubMed ID: 19885684
[TBL] [Abstract][Full Text] [Related]
25. A preliminary study searching for the right dose of tacrolimus in very young (≤4 years) renal transplant patients.
Martial LC; Verstegen RH; Cornelissen EA; Aarnoutse RE; Schreuder MF; Brüggemann RJ
J Pharm Pharmacol; 2016 Nov; 68(11):1366-1372. PubMed ID: 27669677
[TBL] [Abstract][Full Text] [Related]
26. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients.
Staatz CE; Willis C; Taylor PJ; Tett SE
Clin Pharmacol Ther; 2002 Dec; 72(6):660-9. PubMed ID: 12496747
[TBL] [Abstract][Full Text] [Related]
27. A randomized trial comparing renal function in older kidney transplant patients following delayed versus immediate tacrolimus administration.
Andrés A; Budde K; Clavien PA; Becker T; Kessler M; Pisarski P; Fornara P; Burmeister D; Hené RJ; Cassuto-Viguier E;
Transplantation; 2009 Nov; 88(9):1101-8. PubMed ID: 19898206
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of limited sampling strategies for the estimation of mycophenolic acid area under the curve in adult kidney and liver transplant recipients receiving concomitant enteric-coated mycophenolate sodium and tacrolimus.
Pawinski T; Luszczynska P; Durlik M; Majchrzak J; Baczkowska T; Chrzanowska M; Sobiak J; Glyda M; Kuriata-Kordek M; Kamińska D; Krajewska M; Klinger M
Ther Drug Monit; 2013 Dec; 35(6):760-9. PubMed ID: 24192641
[TBL] [Abstract][Full Text] [Related]
29. Influence of CYP3A5 and MDR1 polymorphisms on tacrolimus concentration in the early stage after renal transplantation.
Zhang X; Liu ZH; Zheng JM; Chen ZH; Tang Z; Chen JS; Li LS
Clin Transplant; 2005 Oct; 19(5):638-43. PubMed ID: 16146556
[TBL] [Abstract][Full Text] [Related]
30. Colchicine levels in chronic kidney diseases and kidney transplant recipients using tacrolimus.
Amanova A; Kendi Celebi Z; Bakar F; Caglayan MG; Keven K
Clin Transplant; 2014 Oct; 28(10):1177-83. PubMed ID: 25125128
[TBL] [Abstract][Full Text] [Related]
31. Lessons from routine dose adjustment of tacrolimus in renal transplant patients based on global exposure.
Saint-Marcoux F; Woillard JB; Jurado C; Marquet P
Ther Drug Monit; 2013 Jun; 35(3):322-7. PubMed ID: 23666572
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients.
Jain A; Venkataramanan R; Sharma R; Kwong T; Orloff M; Abt P; Kashyap R; Tsoulfas G; Batzold P; Williamson M; Bozorgzadeh A
Transplantation; 2008 Feb; 85(4):554-60. PubMed ID: 18347534
[TBL] [Abstract][Full Text] [Related]
33. Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen.
Alloway R; Steinberg S; Khalil K; Gourishankar S; Miller J; Norman D; Hariharan S; Pirsch J; Matas A; Zaltzman J; Wisemandle K; Fitzsimmons W; First MR
Transplant Proc; 2005 Mar; 37(2):867-70. PubMed ID: 15848559
[TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
Nakamura Y; Hama K; Katayama H; Soga A; Toraishi T; Yokoyama T; Kihara Y; Jojima Y; Konno O; Iwamoto H; Takeuchi H; Hirano T; Shimazu M
Transplant Proc; 2012 Jan; 44(1):124-7. PubMed ID: 22310595
[TBL] [Abstract][Full Text] [Related]
35. The pharmacokinetics of everolimus in de novo kidney transplant patients receiving tacrolimus: an analysis from the randomized ASSET study.
Rostaing L; Christiaans MH; Kovarik JM; Pascual J
Ann Transplant; 2014 Jul; 19():337-45. PubMed ID: 25017487
[TBL] [Abstract][Full Text] [Related]
36. Chronopharmacokinetics of tacrolimus in kidney transplant recipients: occurrence of acute rejection.
Tada H; Satoh S; Iinuma M; Shimoda N; Murakami M; Hayase Y; Kato T; Suzuki T
J Clin Pharmacol; 2003 Aug; 43(8):859-65. PubMed ID: 12953343
[TBL] [Abstract][Full Text] [Related]
37. Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients.
Press RR; Ploeger BA; den Hartigh J; van der Straaten T; van Pelt J; Danhof M; de Fijter JW; Guchelaar HJ
Ther Drug Monit; 2009 Apr; 31(2):187-97. PubMed ID: 19258929
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics in stable kidney transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations.
van Hooff J; Van der Walt I; Kallmeyer J; Miller D; Dawood S; Moosa MR; Christiaans M; Karpf C; Undre N
Ther Drug Monit; 2012 Feb; 34(1):46-52. PubMed ID: 22249344
[TBL] [Abstract][Full Text] [Related]
39. De novo kidney transplant recipients need higher doses of Advagraf compared with Prograf to get therapeutic levels.
Crespo M; Mir M; Marin M; Hurtado S; Estadella C; Gurí X; Rap O; Moral R; Puig JM; Lloveras J
Transplant Proc; 2009; 41(6):2115-7. PubMed ID: 19715848
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of once- versus twice-daily tacrolimus formulations in kidney transplant patients receiving expanded criteria deceased donor organs: a single-center, randomized study.
Cabello M; García P; González-Molina M; Díez de los Rios MJ; García-Sáiz M; Gutiérrez C; López V; Sola E; Burgos D; Hernández D
Transplant Proc; 2010 Oct; 42(8):3038-40. PubMed ID: 20970603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]